Similarly, a DNA vaccine against murine transcription factor Fos-related antigen 1, which is overexpressed in aggressively proliferating D2F2 murine breast carcinoma have been used against breast cancer development and metastatic progression combining the action of immune effector cells with suppression of tumor angiogenesis [37]. Here, FOSL1 is linked to breast carcinoma.